-Live Mint One of the Modi government's bigger initiatives will be to start implementing a three-decade-old plan to connect 30 rivers New Delhi: Prime Minister Narendra Modi is trying to make good on his promise to tackle India's water woes. He isn't the first Indian leader to make such a vow. Indira Gandhi was among the previous prime ministers who have tried, even though she was skeptical of mega dam projects. She...
More »SEARCH RESULT
Total Matching Records found : 2634
Won't raise allocations under food law: Govt
-The Business Standard Says increase in the subsidised foodgrain allocation will put pressure on the food subsidy bill Union Food Minister Ram Vilas Paswan on Tuesday said the government has no plans to raise subsidised foodgrain allocations under the National Food Security Act (NFSA) from 5 kg to 7 kg a person a month. Under the Act, each eligible person gets 5 kg of rice at Rs 5 a kg or wheat at...
More »India's 93.2% quandary at WTO -Soumya Kanti Ghosh
-The Business Standard WTO reconvenes to re-examine issue of agriculture subsidies, numbers alone suggest that India has a strong case for declining to sign WTO's TFA The World Trade Organisation (WTO) is reconvening in the last week of September to examine the issue of agricultural subsidies against the backdrop of India's refusal to become a signatory to the trade facilitation agreement (TFA) at Bali. Since then, a lot of water has flowed...
More »Aadhaar-subsidy push: Govt for 80% linkage soon in five schemes -Sanjeeb Mukherjee
-The Business Standard PlanCom meets this month to hasten implementation; initial focus on target coverage might cover 300 districts After reposing faith in the Aadhaar project at its cabinet meeting last week, the Narendra Modi government wants Direct Benefits Transfer (DBT) to 80% of beneficiaries in five key schemes "as soon as possible". These include the cooking gas subsidy, where DBT was stalled under the previous government. The other schemes are on transfer...
More »A new order
-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...
More »
